Neurology Neuroimmunology & Neuroinflammation · 2021 · 62 citations · 9 references
Life SciencesImmunologyNeurologyAutoimmunityClinical ImmunologyNeuroimmunologyAutoimmune DiseasesAutoimmune Neurological DisordersDemyelinating DiseasesDemyelinating DisordersImmunosuppressionImmunosuppressive TherapyImmunosuppressive Drug TherapyMedian AgeMedical Records ReviewRelapse-free SurvivalTherapeutic Plasma Exchange
OBJECTIVE: To evaluate the outcomes of immunosuppressive therapy (IST) discontinuation in patients with neuromyelitis optica spectrum disorder (NMOSD) after a sustained remission period. METHODS: We retrospectively reviewed the medical records of 17 patients with antiaquaporin-4 antibody-positive NMOSD who discontinued IST after a relapse-free period of ≥3 years. RESULTS: IST was discontinued at a median age of 40 years (interquartile range [IQR], 32-51) after a median relapse-free period of 62 months (IQR, 52-73). Among the 17 enrolled patients, 14 (82%) relapsed at a median interval of 6 months (IQR, 4-34) after IST discontinuation, 3 (18%) of whom experienced severe attacks; notably, all 3 of these patients had a history of severe attack before IST. These 3 patients received steroids, followed by plasma exchange for acute treatment, but 2 exhibited poor recovery and significant disability worsening at 6 months after relapse. CONCLUSIONS: IST discontinuation may increase the risk of relapse in seropositive patients with NMOSD even after 5 years of remission. Given the potentially devastating consequence of a single attack of NMOSD, caution is advised with IST discontinuation, particularly in patients with severe attack before IST.
9
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett et al. · Neurology · 2015 · 4.5K citations · Full text
Medicine, Neurology, Neuroscience +15
Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica
Su‐Hyun Kim, In Hye Jeong, Jae‐Won Hyun et al. · JAMA Neurology · 2015 · 210 citations
Racial differences in neuromyelitis optica spectrum disorder
Su‐Hyun Kim, Maureen A. Mealy, Michael Levy et al. · Neurology · 2018 · 176 citations · Full text